| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/05/2014 | CN103549420A Traditional Chinese medicine health-care capsule |
| 02/05/2014 | CN103549072A Vital energy-benefiting brain-boosting tea and preparation method thereof |
| 02/05/2014 | CN102949599B Traditional Chinese medicine preparation for reducing blood pressure |
| 02/05/2014 | CN102895166B Foot-bath lotion containing hypertension-controlling drug ingredients |
| 02/05/2014 | CN102600239B Medicament for treating thromboangitis obliterans and preparation method thereof |
| 02/05/2014 | CN102526380B Detection method of coronary artery dredging tablet |
| 02/05/2014 | CN102451333B Method of extracting water-soluble saponin from yellow ginger |
| 02/05/2014 | CN102302507B Medicinal composition for directional controlled release of trace elements and preparation method and application |
| 02/05/2014 | CN102247329B 5,6,7,4'-tetrahydroxyflavone powder injection and preparation method thereof |
| 02/05/2014 | CN101928739B Preparation method of high-density lipoprotein and application thereof |
| 02/05/2014 | CN101874802B Slow-release medicinal composition for treating hypertension and high cholesterol |
| 02/04/2014 | US8642747 Genetic modification of targeted regions of the cardiac conduction system |
| 02/04/2014 | US8642662 Methods of using derivatives of (−)-venlafaxine |
| 02/04/2014 | US8642630 Endogeneous repair factor production accelerators |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
| 02/04/2014 | US8642608 Quinazoline derivatives as VEGF inhibitors |
| 02/04/2014 | US8642592 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 02/04/2014 | US8642590 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 02/04/2014 | US8642586 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same |
| 02/04/2014 | US8642578 Elastin protective polyphenolics and methods of using the same |
| 02/04/2014 | US8642077 Stable pharmaceutical composition and methods of using same |
| 02/04/2014 | US8642066 Sustained drug delivery system |
| 02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |
| 02/04/2014 | CA2573969C Oxidative degradation products of atorvastatin calcium |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 01/30/2014 | WO2014018764A1 Spiro - fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
| 01/30/2014 | WO2014017897A1 New differential-release pharmaceutical composition containing three active principles |
| 01/30/2014 | WO2014017803A1 Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising same |
| 01/30/2014 | WO2014017802A1 Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising same |
| 01/30/2014 | WO2014017643A1 Difluoromethylene compound |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014016585A1 Use of s-pindolol for treating cachexia and sarcopenia |
| 01/30/2014 | WO2014016266A1 Kudzu and phytosterols for use in the treatment of metabolic disorders |
| 01/30/2014 | WO2014015777A1 Method for inducing pluripotent stem cells to differentiate into ventricular myocytes in vitro |
| 01/30/2014 | WO2014015754A1 Broussonetine compound, preparation method therefor, and application thereof |
| 01/30/2014 | WO2014015672A1 Compound preparation of lercanidipine and atorvastatin |
| 01/30/2014 | WO2014015523A1 Novel heteroaryl and heterocycle compounds, compositions and methods |
| 01/30/2014 | WO2014015507A1 Application of shengui capsule in preparing antithrombotic drugs |
| 01/30/2014 | WO2014015462A1 Hawthorn and phytosterols and their effect on metabolic disorders |
| 01/30/2014 | WO2013185048A3 Heterocyclic guanidine f1f0-atpase inhibitors |
| 01/30/2014 | US20140031372 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
| 01/30/2014 | US20140030363 Method and treatment for the reduction of atherosclerosis |
| 01/30/2014 | CA2876508A1 Spiro-fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
| 01/29/2014 | EP2690111A1 Anti-mouse aggrus monoclonal antibody |
| 01/29/2014 | EP2690088A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same |
| 01/29/2014 | EP2690087A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same |
| 01/29/2014 | EP2689784A1 Composition containing ginseng berry extract for treatment of ischemic heart disease, facilitation of blood circulation and angiogenesis |
| 01/29/2014 | EP2689776A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 01/29/2014 | EP2688881A1 New azaspirodecanone compounds as hsl inhibitors |
| 01/29/2014 | EP2548569B1 Stem cell derived paracrine factor h1 for use in reducing cell death in cardiac tissue |
| 01/29/2014 | EP1948158B1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 01/29/2014 | EP1196638B1 Use of the krit1 gene in angiogenesis |
| 01/29/2014 | CN103547562A 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease |
| 01/29/2014 | CN103547281A Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/29/2014 | CN103547274A Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 01/29/2014 | CN103547263A Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/29/2014 | CN103540500A Chrysanthemum wine and preparation method thereof |
| 01/29/2014 | CN103539858A Connective tissue growth factor antibodies |
| 01/29/2014 | CN103539834A Chemerin derived peptide and expressed gene and application thereof |
| 01/29/2014 | CN103539791A Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539780A Substituted pyrazolone compounds as well as use method and application of substituted pyrazolone compounds |
| 01/29/2014 | CN103539777A PI3 kinase regulator as well as use method and application of PI3 kinase regulator |
| 01/29/2014 | CN103539769A Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 01/29/2014 | CN103539760A Phenoxy phenylacetic acid endothelin antagonist, and preparation method and application thereof |
| 01/29/2014 | CN103539735A Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/29/2014 | CN103539709A N-(-1-hydro-indenyl-1-yl)sulfonamide compound and its preparation method and use |
| 01/29/2014 | CN103539659A 2,4-dibenzyloxybenzoic acid derivative and preparation method and application thereof |
| 01/29/2014 | CN103536932A Use of SLC17A5 gene and coded protein thereof in preparing medicines for treating or diagnosing nitrate transfer or metabolic block or disorder related diseases |
| 01/29/2014 | CN103536927A Edaravone composition freeze-dried powder injection |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536910A 细胞色素c注射液 Cytochrome c injection |
| 01/29/2014 | CN103536896A Enalapril composition freeze-dried powder for injection |
| 01/29/2014 | CN103536893A Traditional Chinese medicine composition for treating Raynaud disease |
| 01/29/2014 | CN103536873A Traditional Chinese medicine for treating vertigo caused by deficiency of both liver and kidney |
| 01/29/2014 | CN103536869A Chinese medicinal prescription for treating varicocele |
| 01/29/2014 | CN103536832A Traditional Chinese medicinal composition for treating masturbation or excessive indulgence sequela |
| 01/29/2014 | CN103536822A Medicine for treating osteoproliferation and lumbar disc herniation |
| 01/29/2014 | CN103536815A Traditional Chinese medicinal composition for treating hemorrhoids symptoms |
| 01/29/2014 | CN103536809A Traditional Chinese medicine preparation for treating hypertension and preparation method thereof |
| 01/29/2014 | CN103536808A Capsule used after mitral valve calcification valvuloplasty and preparation method thereof |
| 01/29/2014 | CN103536807A Drug composition used after mitral valve calcification valvuloplasty |
| 01/29/2014 | CN103536806A Traditional Chinese medicine composition for treating alcoholic myocardiopathy |
| 01/29/2014 | CN103536805A Traditional Chinese medicine composition for treating high liver fire |
| 01/29/2014 | CN103536789A Haemorrhoids agent |
| 01/29/2014 | CN103536786A Eucommia ulmoides traditional Chinese medicine preparation |
| 01/29/2014 | CN103536767A Method for preparing preparation for treating palpitation |
| 01/29/2014 | CN103536754A Traditional Chinese medicine formula for treating heart disease |
| 01/29/2014 | CN103536726A External traditional Chinese medicine for treating diabetic foot and preparation method thereof |
| 01/29/2014 | CN103536715A Traditional Chinese medicine formula for treating hypertension |
| 01/29/2014 | CN103536698A New medicine application of traditional Chinese medicinal composition |
| 01/29/2014 | CN103536690A Traditional Chinese medicine oral liquid for reducing blood pressure |
| 01/29/2014 | CN103536687A Health care product capable of improving sleep |
| 01/29/2014 | CN103536673A Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof |
| 01/29/2014 | CN103536672A Traditional Chinese medicinal formula for solving human body relaxation shortcut phenomenon |
| 01/29/2014 | CN103536658A Rhizoma corydalis Chinese medicinal preparation |
| 01/29/2014 | CN103536657A Haemorrhoid treatment lotion |
| 01/29/2014 | CN103536653A Chinese herbal medicine oral liquid for hypertensive patient and preparation method thereof |